Dr. Kevin Brumund is a board-certified head and neck surgeon whose clinical interests include surgery for head and neck cancer and benign tumors, thyroid and parathyroid surgery, and skull base surgery. As a fellowship-trained microvascular surgeon, he is skilled in free tissue transfer for head and neck reconstruction. Dr. Brumund feels that free flap reconstruction plays a vital role in improving patients’ function and quality of life after cancer surgery.
Dr. Brumund obtained his medical degree from Rush Medical College in Chicago. After completing his General Surgery internship at Rush Medical Center, he completed his residency training in Otolaryngology-Head and Neck Surgery at the prestigious University of Iowa Hospitals and Clinics. During his residency training, he was awarded a research fellowship to Paris, France for further education in head and neck surgery and laser cancer resection. He completed his advanced fellowship training in Head and Neck Oncologic Surgery, Skull Base Surgery, and Microvascular Reconstructive Surgery at the University of California, Davis Medical Center.
Dr. Brumund joined the faculty at the University of California, San Diego in the Division of Otolaryngology-Head and Neck Surgery in 2006. He is a member of the multi-disciplinary Head and Neck Oncology team of specialists at the UC San Diego Moores Cancer Center dedicated to the cutting-edge treatment of patients with head and neck cancer. He also has a keen interest in approaches to the cranial base to access skull base tumors, in order to facilitate their excision. He is a member of the American Academy of Otolaryngology-Head and Neck Surgery and the American Head and Neck Society.
Dr. Brumund enjoys working with and teaching residents the principles of patient management and the comprehensive care of the head and neck cancer patient.Research Overview
Diagnosis and treatment of Head and Neck malignancies. Minimally invasive surgical treatment of Head and Neck Cancer. Research Topics
Current Project Titles
- Clinical Trials
- Minimally Invasive Techniques
A Phase 3, Prospective, Open-Label, Multicenter Study of Lymphoseek® - Identified Sentinel Lymph Nodes (SLNs) Relative to the Pathological Status of Non-Sentinel Lymph Nodes in an Elective Neck Dissection (END) in Cutaneous Head and Neck and Intraoral Squamous Cell Carcinoma